cancer research

Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Healy LA et al. - It is possible that patients with unrecognized micrometastatic disease at the time of surgery may report worse systemic symptoms at diagnosis, in particular fatigue and dyspnea, and these and global QOL scores may also identify poorer reserves that may increase in-hospital morbidity and mortality postoperatively.


   

Today in Gastroenterology...keeping you current

Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study
The Lancet - Early Online Publication, 02/09/10

Mesalazine in inflammatory bowel disease: A trendy topic once again
Canadian Journal of Gastroenterology, 02/09/10

Failure of automated telephone outreach with speech recognition to improve colorectal cancer screening
Archives of Internal Medicine, 02/09/10

Today in Hematology/Oncology...keeping you current

FDA Drug Approval Summary: Bevacizumab plus Interferon for Advanced Renal Cell Carcinoma
The Oncologist, 02/09/10

Cancer epidemiology in France in 2010, comparison with the USA
Bulletin du Cancer, 02/09/10

Rectal cancer and adjuvant chemotherapy: which conclusions
Bulletin du Cancer, 02/09/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address